Tan EH - Search Results

1

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).

Ma BB, Goh BC, Lim WT, Hui EP, Tan EH, Lopes Gde L, Lo KW, Li L, Loong H, Foster NR, Erlichman C, King AD, Kam MK, Leung SF, Chan KC, Chan AT. Ma BB, et al. Among authors: tan eh. Invest New Drugs. 2015 Aug;33(4):985-91. doi: 10.1007/s10637-015-0264-0. Epub 2015 Jun 19. Invest New Drugs. 2015. PMID: 26084990 Clinical Trial.

2

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma.

Tan EH, Khoo KS, Wee J, Fong KW, Lee KS, Lee KM, Chua ET, Tan T, Khoo-Tan HS, Yang TL, Au E, Tao M, Ong YK, Chua EJ. Tan EH, et al. Among authors: tan t. Ann Oncol. 1999 Feb;10(2):235-7. doi: 10.1023/a:1008390929826. Ann Oncol. 1999. PMID: 10093695 Free article. Clinical Trial.

3

Concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma of the undifferentiated type.

Ong YK, Tan EH, Wee J, Goh CB, Fong KW, Lee KS, Chua EJ. Ong YK, et al. Among authors: tan eh. Ann Acad Med Singap. 1999 Jul;28(4):525-8. Ann Acad Med Singap. 1999. PMID: 10561766

4

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type.

Foo KF, Tan EH, Leong SS, Wee JT, Tan T, Fong KW, Koh L, Tai BC, Lian LG, Machin D. Foo KF, et al. Among authors: tan t, tan eh. Ann Oncol. 2002 Jan;13(1):150-6. doi: 10.1093/annonc/mdf002. Ann Oncol. 2002. PMID: 11865813 Free article. Clinical Trial.

5

Design of a prognostic index score for metastatic nasopharyngeal carcinoma.

Ong YK, Heng DM, Chung B, Leong SS, Wee J, Fong KW, Tan T, Tan EH. Ong YK, et al. Among authors: tan t, tan eh. Eur J Cancer. 2003 Jul;39(11):1535-41. doi: 10.1016/s0959-8049(03)00310-1. Eur J Cancer. 2003. PMID: 12855259

6

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.

Poon D, Yap SP, Wong ZW, Cheung YB, Leong SS, Wee J, Tan T, Fong KW, Chua ET, Tan EH. Poon D, et al. Among authors: tan t, tan eh. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1312-8. doi: 10.1016/j.ijrobp.2004.01.037. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275714

7

The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis.

Toh CK, Wong EH, Lim WT, Leong SS, Fong KW, Wee J, Tan EH. Toh CK, et al. Among authors: tan eh. Chest. 2004 Dec;126(6):1750-6. doi: 10.1378/chest.126.6.1750. Chest. 2004. PMID: 15596669

8

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.

Leong SS, Wee J, Tay MH, Toh CK, Tan SB, Thng CH, Foo KF, Lim WT, Tan T, Tan EH. Leong SS, et al. Among authors: tan sb, tan t, tan eh. Cancer. 2005 Feb 1;103(3):569-75. doi: 10.1002/cncr.20804. Cancer. 2005. PMID: 15611975 Free article. Clinical Trial.

9

Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma.

Poon D, Chowbay B, Cheung YB, Leong SS, Tan EH. Poon D, et al. Among authors: tan eh. Cancer. 2005 Feb 1;103(3):576-81. doi: 10.1002/cncr.20802. Cancer. 2005. PMID: 15612023 Free article. Clinical Trial.

10

Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.

Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Thirugnanam A, Tan EH. Toh CK, et al. Among authors: tan eh. J Clin Oncol. 2006 May 20;24(15):2245-51. doi: 10.1200/JCO.2005.04.8033. J Clin Oncol. 2006. PMID: 16710022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters